Floctafenine
![]() | |
Systematic (IUPAC) name | |
---|---|
2,3-Dihydroxypropyl 2-{[8-(trifluoromethyl)-4-quinolinyl]amino}benzoate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 23779-99-9 |
ATC code | N02BG04 (WHO) |
PubChem | CID 3360 |
DrugBank |
DB08976 ![]() |
ChemSpider | 3243 |
Chemical data | |
Formula | C20H17F3N2O4 |
Molar mass | 406.355 g/mol |
| |
|
Floctafenine is a non-steroidal anti-inflammatory drug (NSAID).
Synthesis

The scheme involves first the conversion of ortho-trifluoromethyl aniline (1) to a quinolol. The compound is thus condensed with EMME (Ethoxy Methylene Malonic Diethyl Ester) and cyclized thermally (2). That intermediate is then saponified; the resulting acid is decarboxylated and finally converted to the 4-chloroquinoline (3) by reaction with phosphorus oxychloride. The displacement of chlorine with methyl anthranilate (4) then affords the coupled intermediate (5). An ester interchange of that product with glycerol leads to the glyceryl ester. There is thus obtained the NSAID floctafenine.
See also
- Glafenine, a chemically related NSAID
References
- ↑ Mouzin, G.; Cousse, H.; Autin, J. M. (1980). "A New, Convenient Synthesis of Glafenine and Floctafenine". Synthesis 1980: 54. doi:10.1055/s-1980-28923.
|
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.